Effect of Short-Term Antimicrobial Therapy on the Tolerance and Antibiotic Resistance of Multidrug-Resistant Staphylococcus capitis

References

• Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev. 2010;74(3):417–433. doi:10.1128/MMBR.00016-1020805405
   PubMed Web of Science ®Google Scholar
• Harris SR, Clarke IN, Seth-Smith HM, et al. Whole-genome analysis of diverse Chlamydia trachomatis strains identifies phylogenetic relationships masked by current clinical typing. Nat Genet. 2012;44(4):413–419, S411. doi:10.1038/ng.221422406642
   PubMed Web of Science ®Google Scholar
• Choe D, Lee JH, Yoo M, et al. Adaptive laboratory evolution of a genome-reduced Escherichia coli. Nat Commun. 2019;10(1):935. doi:10.1038/s41467-019-08888-630804335
   PubMed Web of Science ®Google Scholar
• Marvig RL, Johansen HK, Molin S, Jelsbak L. Genome analysis of a transmissible lineage of pseudomonas aeruginosa reveals pathoadaptive mutations and distinct evolutionary paths of hypermutators. PLoS Genet. 2013;9(9):e1003741. doi:10.1371/journal.pgen.100374124039595
   PubMed Web of Science ®Google Scholar
• Morelli G, Song Y, Mazzoni CJ, et al. Yersinia pestis genome sequencing identifies patterns of global phylogenetic diversity. Nat Genet. 2010;42(12):1140–1143. doi:10.1038/ng.70521037571
   PubMed Web of Science ®Google Scholar
• Conlan S, Park M, Deming C, et al. Plasmid dynamics in KPC-positive Klebsiella pneumoniae during long-term patient colonization. mBio. 2016;7(3):3. doi:10.1128/mBio.00742-16
   Web of Science ®Google Scholar
• Lazar V, Pal Singh G, Spohn R, et al. Bacterial evolution of antibiotic hypersensitivity. Mol Syst Biol. 2013;9(1):700. doi:10.1038/msb.2013.5724169403
   PubMed Web of Science ®Google Scholar
• Butin M, Martins-Simoes P, Rasigade JP, Picaud JC, Laurent F. Worldwide endemicity of a multidrug-resistant staphylococcus capitis clone involved in neonatal sepsis. Emerg Infect Dis. 2017;23(3):538–539. doi:10.3201/eid2303.16083328221122
   PubMed Web of Science ®Google Scholar
• Cameron DR, Jiang JH, Hassan KA, et al. Insights on virulence from the complete genome of Staphylococcus capitis. Front Microbiol. 2015;6:980. doi:10.3389/fmicb.2015.0098026441910
   PubMed Web of Science ®Google Scholar
• Institute CaLS. Performance Standards for Antimicrobial Susceptibility Testing. 2018:M100
   Google Scholar
• Waterhouse A, Bertoni M, Bienert S, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46(W1):W296–W303. doi:10.1093/nar/gky42729788355
   PubMed Web of Science ®Google Scholar
• Sander P, Springer B, Prammananan T, et al. Fitness cost of chromosomal drug resistance-conferring mutations. Antimicrob Agents Chemother. 2002;46(5):1204–1211. doi:10.1128/AAC.46.5.1204-1211.200211959546
   PubMed Web of Science ®Google Scholar
• Guo B, Abdelraouf K, Ledesma KR, Nikolaou M, Tam VH. Predicting bacterial fitness cost associated with drug resistance. J Antimicrob Chemother. 2012;67(4):928–932. doi:10.1093/jac/dkr56022232512
   PubMed Web of Science ®Google Scholar
• van der Maten E, de Jonge MI, de Groot R, van der Flier M, Langereis JD. A versatile assay to determine bacterial and host factors contributing to opsonophagocytotic killing in hirudin-anticoagulated whole blood. Sci Rep. 2017;7(1):42137. doi:10.1038/srep4213728176849
   PubMed Web of Science ®Google Scholar
• Tsai CJ-Y, Loh JMS, Proft T. Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing. Virulence. 2016;7(3):214–229. doi:10.1080/21505594.2015.113528926730990
   PubMed Web of Science ®Google Scholar
• Sun F, Li C, Jeong D, Sohn C, He C, Bae T. In the Staphylococcus aureus two-component system sae, the response regulator SaeR binds to a direct repeat sequence and DNA binding requires phosphorylation by the sensor kinase SaeS. J Bacteriol. 2010;192(8):2111–2127. doi:10.1128/JB.01524-0920172998
   PubMed Web of Science ®Google Scholar
• Mehta AP, Hanes JW, Abdelwahed SH, Hilmey DG, Hanzelmann P, Begley TP. Catalysis of a new ribose carbon-insertion reaction by the molybdenum cofactor biosynthetic enzyme MoaA. Biochemistry. 2013;52(7):1134–1136. doi:10.1021/bi301602623286307
   PubMed Web of Science ®Google Scholar
• Yokoyama K, Leimkuhler S. The role of FeS clusters for molybdenum cofactor biosynthesis and molybdoenzymes in bacteria. Biochim Biophys Acta. 2015;1853(6):1335–1349. doi:10.1016/j.bbamcr.2014.09.02125268953
   PubMed Web of Science ®Google Scholar
• Wi YM, Greenwood-Quaintance KE, Brinkman CL, Lee JYH, Howden BP, Patel R. Rifampicin resistance in Staphylococcus epidermidis: molecular characterisation and fitness cost of rpoB mutations. Int J Antimicrob Agents. 2018;51(5):670–677. doi:10.1016/j.ijantimicag.2017.12.01929287710
   PubMed Web of Science ®Google Scholar
• Wichelhaus TA, Schafer V, Brade V, Boddinghaus B. Molecular characterization of rpoB mutations conferring cross-resistance to rifamycins on methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1999;43(11):2813–2816. doi:10.1128/AAC.43.11.281310543773
   PubMed Web of Science ®Google Scholar
• Bassenden AV, Rodionov D, Shi K, Berghuis AM. Structural analysis of the tobramycin and gentamicin clinical resistome reveals limitations for next-generation aminoglycoside design. ACS Chem Biol. 2016;11(5):1339–1346. doi:10.1021/acschembio.5b0107026900880
   PubMed Web of Science ®Google Scholar
• Becker K, Heilmann C, Peters G. Coagulase-negative staphylococci. Clin Microbiol Rev. 2014;27(4):870–926.25278577
   PubMed Web of Science ®Google Scholar
• Dong Y, Speer CP, Glaser K. Beyond sepsis: staphylococcus epidermidis is an underestimated but significant contributor to neonatal morbidity. Virulence. 2018;9(1):621–633. doi:10.1080/21505594.2017.141911729405832
   PubMed Web of Science ®Google Scholar
• Al Hennawi HET, Mahdi EM, Memish ZA. Native valve Staphylococcus capitis infective endocarditis: a mini review. Infection. 2019.
   Google Scholar
• Laurent F, Butin M. Staphylococcus capitis and NRCS-A clone: the story of an unrecognized pathogen in neonatal intensive care units. Clin Microbiol Infect. 2019;25(9):1081–1085. doi:10.1016/j.cmi.2019.03.00930928561
   PubMed Web of Science ®Google Scholar
• Tevell S, Hellmark B, Nilsdotter-Augustinsson A, Soderquist B. Staphylococcus capitis isolated from prosthetic joint infections. Eur J Clin Microbiol Infect Dis. 2017;36(1):115–122. doi:10.1007/s10096-016-2777-727680718
   PubMed Web of Science ®Google Scholar
• Carter GP, Ussher JE, Da Silva AG, et al. Genomic analysis of multiresistant staphylococcus capitis associated with neonatal sepsis. Antimicrob Agents Chemother. 2018;62(11):11. doi:10.1128/AAC.00898-18
   Web of Science ®Google Scholar
• Butin M, Martins-Simoes P, Pichon B, et al. Emergence and dissemination of a linezolid-resistant Staphylococcus capitis clone in Europe. J Antimicrob Chemother. 2017;72(4):1014–1020. doi:10.1093/jac/dkw51627999045
   PubMed Web of Science ®Google Scholar
• O’Neill AJ, Huovinen T, Fishwick CW, Chopra I. Molecular genetic and structural modeling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampin resistance genotypes in relation to clinical prevalence. Antimicrob Agents Chemother. 2006;50(1):298–309. doi:10.1128/AAC.50.1.298-309.200616377701
   PubMed Web of Science ®Google Scholar
• Munck C, Gumpert HK, Wallin AI, Wang HH, Sommer MO. Prediction of resistance development against drug combinations by collateral responses to component drugs. Sci Transl Med. 2014;6(262):262ra156. doi:10.1126/scitranslmed.3009940
   PubMed Web of Science ®Google Scholar
• Jacoby GA, Blaser MJ, Santanam P, et al. Appearance of amikacin and tobramycin resistance due to 4ʹ-aminoglycoside nucleotidyltransferase [ANT(4ʹ)-II] in gram-negative pathogens. Antimicrob Agents Chemother. 1990;34(12):2381–2386. doi:10.1128/AAC.34.12.23811965106
   PubMed Web of Science ®Google Scholar
• Miller GH, Sabatelli FJ, Hare RS, et al. The most frequent aminoglycoside resistance mechanisms–changes with time and geographic area: a reflection of aminoglycoside usage patterns? Aminoglycoside Resistance Study Groups. Clin Infect Dis. 1997;24(Suppl 1):S46–62. doi:10.1093/clinids/24.Supplement_1.S468994779
   PubMed Web of Science ®Google Scholar
• Nichol D, Rutter J, Bryant C, et al. Antibiotic collateral sensitivity is contingent on the repeatability of evolution. Nat Commun. 2019;10(1):334. doi:10.1038/s41467-018-08098-630659188
   PubMed Web of Science ®Google Scholar
• Imamovic L, Sommer MO. Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development. Sci Transl Med. 2013;5(204):204ra132. doi:10.1126/scitranslmed.3006609
   PubMed Web of Science ®Google Scholar
• Shapiro RS. mSphere of influence: evolutionary strategies to sensitize drug-resistant pathogens. mSphere. 2019;4:3. doi:10.1128/mSphere.00313-19
   Web of Science ®Google Scholar
• Kim S, Lieberman TD, Kishony R. Alternating antibiotic treatments constrain evolutionary paths to multidrug resistance. Proc Natl Acad Sci U S A. 2014;111(40):14494–14499. doi:10.1073/pnas.140980011125246554
   PubMed Web of Science ®Google Scholar
• Liu Q, Yeo WS, Bae T. The SaeRS Two-Component System of Staphylococcus aureus. Genes (Basel). 2016;7(10):10. doi:10.3390/genes7100081
   Web of Science ®Google Scholar